SFXN1 and neoplasm: report that SFXN1 knockdown significantly reduced cell proliferation and migration in vitro, potentially by inhibiting ERK phosphorylation and CCL20 expression; in vivo, targeting SFXN1 decreased Tregs infiltration and suppressed tumor growth (60).